<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>CatsWannaBeCats.Com | Hyldgaard Bonner | Activity</title>
	<link>https://www.catswannabecats.com/members/quailkale6/activity/</link>
	<atom:link href="https://www.catswannabecats.com/members/quailkale6/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Hyldgaard Bonner.</description>
	<lastBuildDate>Mon, 29 Jun 2026 10:35:48 -0400</lastBuildDate>
	<generator>https://buddypress.org/?v=7.2.0</generator>
	<language>en-CA</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">37c7103fd7683558ad2c1ba530e5f2c5</guid>
				<title>Hyldgaard Bonner posted an update: PURPOSE This study aimed to demonstrate the role of [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/23719/</link>
				<pubDate>Sun, 08 Jun 2025 10:24:02 -0400</pubDate>

									<content:encoded><![CDATA[<p>PURPOSE This study aimed to demonstrate the role of fractional concentration of exhaled nitric oxide (FeNO) in association with Global Initiative for Asthma (GINA) guidelines for treatment of adult patients with asthma. METHODS It was a prospective and randomized study. The symptomatic asthmatic patients were randomly divided into two groups GINA&hellip;<span class="activity-read-more" id="activity-read-more-23719"><a href="https://www.catswannabecats.com/activity/p/23719/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">014e09abe36588f670aedab5c1417421</guid>
				<title>Hyldgaard Bonner posted an update: Scope The development of novel compounds that trigger [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/8829/</link>
				<pubDate>Sat, 31 May 2025 21:45:10 -0400</pubDate>

									<content:encoded><![CDATA[<p>Scope The development of novel compounds that trigger non-apoptotic cell death may represent alternative therapeutic strategies for esophageal squamous cell carcinoma (ESCC) treatment. Cellular senescence suppresses tumorigenesis by halting the proliferation of tumor cells, implying the induction of senescence as a promising anticancer strategy,&hellip;<span class="activity-read-more" id="activity-read-more-8829"><a href="https://www.catswannabecats.com/activity/p/8829/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">efc5a8a269e67a92b39828a53c9a2fb8</guid>
				<title>Hyldgaard Bonner became a registered member</title>
				<link>https://www.catswannabecats.com/activity/p/8676/</link>
				<pubDate>Sat, 31 May 2025 21:31:29 -0400</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>